All > Massachusetts Investigators

Robert Edelstein, MD

Merrimack Urology Associates, PC

Chelmsford, Massachusetts - 01824 (978-256-6955)

CLINICAL TRIALS 1
CONDITIONS2
INTERVENTIONS1
SINCE2005

PROLIEVE Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)

September 2005 - September 2015

Hyperplasia

Prostatic Hyperplasia

Prolieve® Thermodilatation System

Learn about TrialX Patient Recruitment services

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Robert Edelstein, MD

Merrimack Urology Associates, PC

Massimo Loda, MD

Suzanne Shusterman

Patrick Y. Wen, MD

Lewis B. Silverman, MD

Kay Kehoe, Coordinator

Jennifer Brown, MD

Rachel A. Freedman

Edwin P. Alyea, MD

F. Stephen Hodi, MD

Beth A. Overmoyer, MD, FACP